Clinical Trial Update: Durvalumab, Cetuximab and Radiotherapy in Head Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/phase 2 trial evaluating durvalumab with cetuximab and radiotherapy in head and neck cancer; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Durvalumab (durvalumab)

Snippet

Sponsor: Azienda Ospedaliero-Universitaria Careggi | Conditions: Head and Neck Neoplasms | Phase 1, Phase 2 | Status: UNKNOWN